nodes	percent_of_prediction	percent_of_DWPC	metapath
Medrysone—Ulcerative keratitis—Erlotinib—kidney cancer	0.0781	0.113	CcSEcCtD
Medrysone—Impaired healing—Temsirolimus—kidney cancer	0.0635	0.0922	CcSEcCtD
Medrysone—NR3C1—urine—kidney cancer	0.0577	0.215	CbGeAlD
Medrysone—Nerve injury—Paclitaxel—kidney cancer	0.0525	0.0762	CcSEcCtD
Medrysone—Impaired healing—Everolimus—kidney cancer	0.0473	0.0686	CcSEcCtD
Medrysone—Impaired healing—Sunitinib—kidney cancer	0.0395	0.0573	CcSEcCtD
Medrysone—SERPINA6—nephron tubule—kidney cancer	0.0355	0.132	CbGeAlD
Medrysone—SERPINA6—renal system—kidney cancer	0.0322	0.12	CbGeAlD
Medrysone—SERPINA6—kidney—kidney cancer	0.0312	0.116	CbGeAlD
Medrysone—Viral infection—Temsirolimus—kidney cancer	0.0304	0.0442	CcSEcCtD
Medrysone—Keratitis—Erlotinib—kidney cancer	0.0304	0.0441	CcSEcCtD
Medrysone—SERPINA6—cortex of kidney—kidney cancer	0.0304	0.113	CbGeAlD
Medrysone—Viral infection—Everolimus—kidney cancer	0.0226	0.0328	CcSEcCtD
Medrysone—Viral infection—Sunitinib—kidney cancer	0.0189	0.0274	CcSEcCtD
Medrysone—Keratitis—Paclitaxel—kidney cancer	0.0177	0.0257	CcSEcCtD
Medrysone—NR3C1—nephron tubule—kidney cancer	0.0155	0.0578	CbGeAlD
Medrysone—Conjunctivitis—Temsirolimus—kidney cancer	0.0149	0.0217	CcSEcCtD
Medrysone—Keratitis—Capecitabine—kidney cancer	0.0145	0.0211	CcSEcCtD
Medrysone—NR3C1—renal system—kidney cancer	0.0141	0.0525	CbGeAlD
Medrysone—NR3C1—kidney—kidney cancer	0.0137	0.0508	CbGeAlD
Medrysone—Eye irritation—Paclitaxel—kidney cancer	0.0134	0.0195	CcSEcCtD
Medrysone—NR3C1—cortex of kidney—kidney cancer	0.0133	0.0494	CbGeAlD
Medrysone—Hydrocortisone—ANXA1—kidney cancer	0.0133	0.315	CrCbGaD
Medrysone—Viral infection—Paclitaxel—kidney cancer	0.0127	0.0184	CcSEcCtD
Medrysone—NR3C1—gonad—kidney cancer	0.0127	0.0471	CbGeAlD
Medrysone—NR3C1—cardiac atrium—kidney cancer	0.0126	0.047	CbGeAlD
Medrysone—Conjunctivitis—Everolimus—kidney cancer	0.0111	0.0161	CcSEcCtD
Medrysone—Eye irritation—Capecitabine—kidney cancer	0.011	0.016	CcSEcCtD
Medrysone—Conjunctivitis—Erlotinib—kidney cancer	0.0107	0.0156	CcSEcCtD
Medrysone—Vision blurred—Pazopanib—kidney cancer	0.0107	0.0155	CcSEcCtD
Medrysone—Keratitis—Doxorubicin—kidney cancer	0.00935	0.0136	CcSEcCtD
Medrysone—Visual disturbance—Paclitaxel—kidney cancer	0.00878	0.0128	CcSEcCtD
Medrysone—Vision blurred—Everolimus—kidney cancer	0.00842	0.0122	CcSEcCtD
Medrysone—Pain—Temsirolimus—kidney cancer	0.00838	0.0122	CcSEcCtD
Medrysone—Drospirenone—BCHE—kidney cancer	0.00818	0.194	CrCbGaD
Medrysone—Pain—Pazopanib—kidney cancer	0.0079	0.0115	CcSEcCtD
Medrysone—Stinging—Doxorubicin—kidney cancer	0.00749	0.0109	CcSEcCtD
Medrysone—Hypersensitivity—Temsirolimus—kidney cancer	0.00722	0.0105	CcSEcCtD
Medrysone—Viral infection—Doxorubicin—kidney cancer	0.00672	0.00975	CcSEcCtD
Medrysone—Pain—Vinblastine—kidney cancer	0.00626	0.00909	CcSEcCtD
Medrysone—Conjunctivitis—Paclitaxel—kidney cancer	0.00624	0.00905	CcSEcCtD
Medrysone—Pain—Everolimus—kidney cancer	0.00624	0.00905	CcSEcCtD
Medrysone—Pain—Erlotinib—kidney cancer	0.00602	0.00873	CcSEcCtD
Medrysone—Visual impairment—Paclitaxel—kidney cancer	0.00555	0.00806	CcSEcCtD
Medrysone—Pain—Sorafenib—kidney cancer	0.00541	0.00786	CcSEcCtD
Medrysone—Hypersensitivity—Vinblastine—kidney cancer	0.00539	0.00783	CcSEcCtD
Medrysone—Hypersensitivity—Everolimus—kidney cancer	0.00537	0.0078	CcSEcCtD
Medrysone—Pain—Sunitinib—kidney cancer	0.00521	0.00756	CcSEcCtD
Medrysone—Conjunctivitis—Capecitabine—kidney cancer	0.00512	0.00743	CcSEcCtD
Medrysone—Pain—Dactinomycin—kidney cancer	0.00493	0.00716	CcSEcCtD
Medrysone—Vision blurred—Paclitaxel—kidney cancer	0.00472	0.00686	CcSEcCtD
Medrysone—Hypersensitivity—Sorafenib—kidney cancer	0.00466	0.00677	CcSEcCtD
Medrysone—Visual impairment—Capecitabine—kidney cancer	0.00455	0.00661	CcSEcCtD
Medrysone—Hypersensitivity—Sunitinib—kidney cancer	0.00449	0.00651	CcSEcCtD
Medrysone—Pain—Vincristine—kidney cancer	0.00441	0.00639	CcSEcCtD
Medrysone—Hypersensitivity—Dactinomycin—kidney cancer	0.00425	0.00617	CcSEcCtD
Medrysone—Pain—Gemcitabine—kidney cancer	0.00418	0.00607	CcSEcCtD
Medrysone—Vision blurred—Capecitabine—kidney cancer	0.00388	0.00563	CcSEcCtD
Medrysone—Hypersensitivity—Vincristine—kidney cancer	0.0038	0.00551	CcSEcCtD
Medrysone—Drospirenone—PTGS2—kidney cancer	0.00377	0.0895	CrCbGaD
Medrysone—Megestrol acetate—ABCB1—kidney cancer	0.00367	0.0872	CrCbGaD
Medrysone—Pain—Paclitaxel—kidney cancer	0.0035	0.00508	CcSEcCtD
Medrysone—Conjunctivitis—Doxorubicin—kidney cancer	0.0033	0.00479	CcSEcCtD
Medrysone—Hypersensitivity—Paclitaxel—kidney cancer	0.00301	0.00438	CcSEcCtD
Medrysone—Visual impairment—Doxorubicin—kidney cancer	0.00294	0.00426	CcSEcCtD
Medrysone—Pain—Capecitabine—kidney cancer	0.00287	0.00417	CcSEcCtD
Medrysone—Methylprednisolone—ABCB1—kidney cancer	0.00281	0.0668	CrCbGaD
Medrysone—Vision blurred—Doxorubicin—kidney cancer	0.0025	0.00363	CcSEcCtD
Medrysone—Hypersensitivity—Capecitabine—kidney cancer	0.00247	0.00359	CcSEcCtD
Medrysone—Progesterone—CYP1A1—kidney cancer	0.00232	0.0552	CrCbGaD
Medrysone—Testosterone—CYP1A1—kidney cancer	0.0022	0.0522	CrCbGaD
Medrysone—Prednisolone—ABCB1—kidney cancer	0.00198	0.0471	CrCbGaD
Medrysone—Pain—Doxorubicin—kidney cancer	0.00185	0.00269	CcSEcCtD
Medrysone—Hypersensitivity—Doxorubicin—kidney cancer	0.00159	0.00231	CcSEcCtD
Medrysone—Hydrocortisone—ABCB1—kidney cancer	0.00152	0.036	CrCbGaD
Medrysone—Progesterone—ABCB1—kidney cancer	0.00123	0.0293	CrCbGaD
Medrysone—Testosterone—ABCB1—kidney cancer	0.00117	0.0277	CrCbGaD
